Gene · 9476
Papers2,888
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 2,888
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Comprehensive exploration of programmed cell death landscape in lung adenocarcinoma combining multi-omic analysis and experimental verification. | Sci Rep | 2025 | 39948103 | PubTator, text mining | PubMed |
| Metastatic Hobnail Papillary Thyroid Carcinoma Initially Diagnosed by Pleural Effusion: Case Report of a Rare and Intriguing Entity. | Diagn Cytopathol | 2025 | 39887598 | PubTator, text mining | PubMed |
| Spontaneous Transformation from Lung Adenocarcinoma to MYC-amplified Large Cell Neuroendocrine Carcinoma. | Pathol Int | 2025 | 39868963 | PubTator, text mining | PubMed |
| Diagnostic value of glypican-1; a new marker differentiating pulmonary squamous cell carcinoma from adenocarcinoma: immunohistochemical study on Egyptian series. | Clin Exp Med | 2025 | 39797955 | PubTator, text mining | PubMed |
| Pulmonary pleomorphic carcinoma: A rare case showing arterial carcinomatosis mimicking pulmonary artery intimal sarcoma. | Pathol Int | 2025 | 39783178 | PubTator, text mining | PubMed |
| Complex immunohistochemical and molecular study on 5 cases of ovarian juvenile granulosa cell tumors reveals a consistent alteration in the PI3K/AKT/mTOR signaling pathway. | Diagn Pathol | 2025 | 39773640 | PubTator, text mining | PubMed |
| Charge of karyopherins and nuclear FG-Nups are key ingredients of nucleocytoplasmic transport. | Biophys J | 2025 | 39600095 | PubTator, text mining | PubMed |
| Clinicopathological features and outcomes of rare lung adenocarcinoma metastasis to the thyroid gland: A single-center, 11-year experience. | Thorac Cancer | 2025 | 39558503 | PubTator, text mining | PubMed |
| Clinicopathological diagnosis of axillary signet-ring cell-like/histiocytoid carcinoma: A case report and literature review. | Histol Histopathol | 2025 | 39473348 | PubTator, text mining | PubMed |
| Clear Cell Adenocarcinoma of the Urinary Tract Primary to the Renal Pelvis: A Multi-institutional Clinicopathologic and Molecular Study of Five Patients. | Am J Surg Pathol | 2025 | 39450999 | PubTator, text mining | PubMed |
| Large-cell Basaloid Adenocarcinoma of the Lung: A Clinicopathologic Study of 12 Cases of a Distinctive Form of Lung Cancer Often Mistaken for Large-cell Neuroendocrine Carcinoma. | Am J Surg Pathol | 2025 | 39450943 | PubTator, text mining | PubMed |
| Low-grade Nasopharyngeal Papillary Adenocarcinoma: A Clinicopathologic Series of 35 Cases. | Am J Surg Pathol | 2025 | 39450942 | PubTator, text mining | PubMed |
| Aberrant Expression of Pneumocytic Markers (TTF-1 and Napsin-A) in Biliary Duct and Gallbladder Adenocarcinomas; A Potential Diagnostic Pitfall. | Int J Surg Pathol | 2025 | 39370909 | PubTator, text mining | PubMed |
| Napsin-A Immunohistochemistry in the Diagnosis of Pulmonary Alveolar Proteinosis. | Arch Pathol Lab Med | 2025 | 39370148 | PubTator, text mining | PubMed |
| Diagnostic and Predictive Immunocytochemistry in Lung Cancer. | Acta Cytol | 2025 | 39299230 | PubTator, text mining | PubMed |
| Cytologic Findings and Ancillary Tests Results of Sclerosing Pneumocytoma: Our Institutional Experience. | Diagn Cytopathol | 2025 | 39162254 | PubTator, text mining | PubMed |
| Napsin A Immunoreactivity in "Hobnail" Epithelium in Benign Endometrial and Endocervical Polyps. | Int J Gynecol Pathol | 2025 | 38781161 | PubTator, text mining | PubMed |
| Unraveling disulfidptosis for prognostic modeling and personalized treatment strategies in lung adenocarcinoma. | Future Sci OA | 2024 | 39587729 | PubTator, text mining | PubMed |
| Characterization of Nonsmall Cell Lung Carcinoma in Limited Biopsy Samples and Identifying Optimal Immunohistochemical Marker Combinations in Resource-Constrained Setup: An Institutional Experience. | Avicenna J Med | 2024 | 39584166 | PubTator, text mining | PubMed |
| Biological and clinical characteristics of non-small cell lung cancer non-specific subtype. | Heliyon | 2024 | 39583818 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9476/papers?page=10